T099: High efficacy and durability of second-line therapy with pembrolizumab, gemcitabine, vinorelbine, and liposomal doxorubicin in the phase II study for relapsed and refractory...

por Moskowitz, Alison J., Shah, Gunjan, Schöder, Heiko, Ganesan, Nivetha, Hancock, Helen, Davey, Theresa, Perez, Leslie, Sohail, Samia, Santarosa, Alayna, Capadona, Charisse, Munayirji, Brittney, Kumar, Anita, Lahoud, Oscar, Batlevi, Connie, Hamlin, Paul, Straus, David J., Owens, Colette, Caron, Philip, Intlekofer, Andrew, Hamilton, Audrey, Horwitz, Steven, Falchi, Lorenzo, Johnson, William, Palomba, Lia, Noy, Ariela, Matasar, Matthew, Pongas, Georgios, Salles, Gilles, Vardhana, Santosha, Sanin, Beatriz Wills, Yahalom, Joachim, Dogan, Ahmet, Zelenetz, Andrew, Moskowitz, Craig H.
Publicado 2022